Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on Memantine to Rivastigmine in Alzheimer's Disease
NCT00234637Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2003
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of memantine in Alzheimer's disease (AD), sponsored by Novartis. Started Nov 2003; status: completed.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00234637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234637.